Showing results (3981-3990 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|December 13, 2025
Phase I Study of Bevacizumab and Temsirolimus Combination Therapy in Advanced Malignancies: Safety, Efficacy, and Ovarian Cancer ExpansionSarina A Piha-Paul, Chieh Tseng, Emily Thompson, et al.
The Oncologist|December 13, 2025
Choice of oncologist and influencing factors: analysis of the Pancreatic Cancer Action Network registryRajiv Agarwal, Jennifer G Whisenant, Lili Sun, et al.
The Oncologist|December 5, 2025
Estradiol levels in women with hormone receptor-positive advanced breast cancer on fulvestrant therapyShuqin Dai, Yanling Wen, Xingping Wu, et al.
The Oncologist|December 9, 2025
Polypharmacy among people diagnosed with colorectal cancer in Australia: a population-based cohort studyBenjamin Daniels, Monica Tang, Maria Aslam, et al.
The Oncologist|September 18, 2012
Effectiveness of multidimensional cancer survivor rehabilitation and cost-effectiveness of cancer rehabilitation in general: a systematic reviewJanne C Mewes, Lotte M G Steuten, Maarten J Ijzerman, et al.
The Oncologist|August 4, 2012
Patient-clinician information engagement improves adherence to colorectal cancer surveillance after curative treatment: results from a longitudinal studyAndy S L Tan, Mihaela Moldovan-Johnson, Sarah Parvanta, et al.
The Oncologist|August 9, 2012
Prognostic significance of TOP2A gene dosage in HER-2-negative breast cancerAnna J Zaczek, Aleksandra Markiewicz, Barbara Seroczynska, et al.
The Oncologist|September 4, 2012
The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapiesPanagiota Economopoulou, Virginia G Kaklamani, Kalliopi Siziopikou
The Oncologist|October 2, 2012
Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanomaPascale Dequen, Paul Lorigan, Jeroen P Jansen, et al.
The Oncologist|August 11, 2020
A Phase I Trial of Trametinib in Combination with Sorafenib in Patients with Advanced Hepatocellular CancerRichard Kim, Elaine Tan, Emily Wang, et al.
Pageof 571